Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Gibbons

Showing results (261-270 of 523) with videos related to

Pageof 53
Sort By:
Reproductive Health|November 28, 2024
INSIGHT-2: mechanistic studies into pregnancy complications and their impact on maternal and child health-study protocolCarlotta Valensin, Emilie J M Côté, Daniela Pereira-Carvalho, et al.
The Journal of Clinical Investigation|September 6, 2017
Fibroblast-specific inhibition of TGF-β1 signaling attenuates lung and tumor fibrosisYing Wei, Thomas J Kim, David H Peng, et al.
Oncoimmunology|January 4, 2018
Overcoming resistance to anti-PD immunotherapy in a syngeneic mouse lung cancer model using locoregional virotherapyXiang Yan, Li Wang, Ran Zhang, et al.
Epidemiology and Infection|February 1, 2014
The disease burden of hepatitis B, influenza, measles and salmonellosis in Germany: first results of the burden of communicable diseases in Europe studyD Plass, M-J J Mangen, A Kraemer, et al.
Molecular Cancer Research : MCR|December 1, 2010
miR-200 Inhibits lung adenocarcinoma cell invasion and metastasis by targeting Flt1/VEGFR1Jonathon D Roybal, Yi Zang, Young-Ho Ahn, et al.
Cell Reports|December 14, 2022
EGFR-phosphorylated GDH1 harmonizes with RSK2 to drive CREB activation and tumor metastasis in EGFR-activated lung cancerJiHoon Kang, Jaemoo Chun, Jung Seok Hwang, et al.
Frontiers in Oncology|April 9, 2024
Case report: Molecular profiling facilitates the diagnosis of a challenging case of lung cancer with choriocarcinoma featuresHui Li, Xin Hu, Matthew S Ning, et al.
Cancer Research|October 12, 2011
Targets of the tumor suppressor miR-200 in regulation of the epithelial-mesenchymal transition in cancerMark J Schliekelman, Don L Gibbons, Vitor M Faca, et al.
The Oncologist|July 2, 2020
A Phase II Trial of Alisertib (MLN8237) in Salvage Malignant MesotheliomaCarl M Gay, Yanhong Zhou, J Jack Lee, et al.
Plos One|November 27, 2013
The pathogen- and incidence-based DALY approach: an appropriate [corrected] methodology for estimating the burden of infectious diseasesMarie-Josée J Mangen, Dietrich Plass, Arie H Havelaar, et al.
Pageof 53

Showing results (261-270 of 523) with videos related to

Sort By:
Pageof 53
Reproductive Health|November 28, 2024
INSIGHT-2: mechanistic studies into pregnancy complications and their impact on maternal and child health-study protocolCarlotta Valensin, Emilie J M Côté, Daniela Pereira-Carvalho, et al.
The Journal of Clinical Investigation|September 6, 2017
Fibroblast-specific inhibition of TGF-β1 signaling attenuates lung and tumor fibrosisYing Wei, Thomas J Kim, David H Peng, et al.
Oncoimmunology|January 4, 2018
Overcoming resistance to anti-PD immunotherapy in a syngeneic mouse lung cancer model using locoregional virotherapyXiang Yan, Li Wang, Ran Zhang, et al.
Epidemiology and Infection|February 1, 2014
The disease burden of hepatitis B, influenza, measles and salmonellosis in Germany: first results of the burden of communicable diseases in Europe studyD Plass, M-J J Mangen, A Kraemer, et al.
Molecular Cancer Research : MCR|December 1, 2010
miR-200 Inhibits lung adenocarcinoma cell invasion and metastasis by targeting Flt1/VEGFR1Jonathon D Roybal, Yi Zang, Young-Ho Ahn, et al.
Cell Reports|December 14, 2022
EGFR-phosphorylated GDH1 harmonizes with RSK2 to drive CREB activation and tumor metastasis in EGFR-activated lung cancerJiHoon Kang, Jaemoo Chun, Jung Seok Hwang, et al.
Frontiers in Oncology|April 9, 2024
Case report: Molecular profiling facilitates the diagnosis of a challenging case of lung cancer with choriocarcinoma featuresHui Li, Xin Hu, Matthew S Ning, et al.
Cancer Research|October 12, 2011
Targets of the tumor suppressor miR-200 in regulation of the epithelial-mesenchymal transition in cancerMark J Schliekelman, Don L Gibbons, Vitor M Faca, et al.
The Oncologist|July 2, 2020
A Phase II Trial of Alisertib (MLN8237) in Salvage Malignant MesotheliomaCarl M Gay, Yanhong Zhou, J Jack Lee, et al.
Plos One|November 27, 2013
The pathogen- and incidence-based DALY approach: an appropriate [corrected] methodology for estimating the burden of infectious diseasesMarie-Josée J Mangen, Dietrich Plass, Arie H Havelaar, et al.
Pageof 53